Form 8-K - Current report:
SEC Accession No. 0001558370-25-006531
Filing Date
2025-05-06
Accepted
2025-05-06 17:05:28
Documents
17
Period of Report
2025-05-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20250502x8k.htm   iXBRL 8-K 43310
2 EX-10.1 cydy-20250502xex10d1.htm EX-10.1 124076
3 EX-99.1 cydy-20250502xex99d1.htm EX-99.1 10843
4 GRAPHIC cydy-20250502xex10d1002.jpg GRAPHIC 5338
  Complete submission text file 0001558370-25-006531.txt   345116

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20250502.xsd EX-101.SCH 3263
6 EX-101.LAB cydy-20250502_lab.xml EX-101.LAB 16918
7 EX-101.PRE cydy-20250502_pre.xml EX-101.PRE 11937
19 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20250502x8k_htm.xml XML 4261
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 25918199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)